“The real drivers of this market are the biotech companies — they are the ones developing the new treatments,” Heffner said, noting that there have already been some notable successes in treating melanoma and bladder cancer. “They are really looking for a cure here, and that’s what makes this so revolutionary.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.